Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05814419 · ClinicalTrials.gov registry record
Familial Hyperlipidemia Family Registry
A clinical trial, sponsored by Poudre Valley Health System.
- Completed
- Registry status
- 11
- Enrollment target
NCT05814419: Completed study, sponsored by Poudre Valley Health System.
NCT05814419 is a clinical trial that has completed, run by Poudre Valley Health System. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05814419 has completed, sponsored by Poudre Valley Health System.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia (FH), immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment. The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease.
Primary Outcome
Individuals with elevated cholesterol group with familial hypercholesterolemia genotype.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2025-05-29 |
What the finished NCT05814419 record still lists
NCT05814419 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05814419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05814419 about?
NCT05814419 is a clinical study titled "Familial Hyperlipidemia Family Registry". If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia (FH), immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genet...
What is the current status of trial NCT05814419?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2023-02-17. Estimated completion is 2025-05-29.
Who is sponsoring clinical trial NCT05814419?
This trial is sponsored by Poudre Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI